Treatment Outcomes with Biosimilars: Be Aware of the Nocebo Effect

por Rezk, Mourad F., Pieper, Burkhard
Publicado 2017

To See or NOsee: The Debate on the Nocebo Effect and Optimizing the Use of Biosimilars

por Rezk, Mourad F., Pieper, Burkhard
Publicado 2018

Correction to: To See or NOsee: The Debate on the Nocebo Effect and Optimizing the Use of Biosimilars

por Rezk, Mourad F., Pieper, Burkhard
Publicado 2018

Unlocking the Value of Anti-TNF Biosimilars: Reducing Disease Burden and Improving Outcomes in Chronic Immune-Mediated Inflammatory Diseases: A Narrative Review

por Rezk, Mourad F., Pieper, Burkhard
Publicado 2020

Correction to: Unlocking the Value of Anti-TNF Biosimilars: Reducing Disease Burden and Improving Outcomes in Chronic Immune-Mediated Inflammatory Diseases: A Narrative Review

por Rezk, Mourad F., Pieper, Burkhard
Publicado 2020

Real-World Evidence on Etanercept Biosimilar SB4 in Etanercept-Naïve or Switching Patients: A Systematic Review

por Ebbers, Hans C., Pieper, Burkhard, Issa, Amine, Addison, Janet, Freudensprung, Ulrich, Rezk, Mourad F.
Publicado 2019

Treatment journey in rheumatoid arthritis with biosimilars: from better access to good disease control through cost savings and prevention of nocebo effects

por Smolen, Josef S, Caporali, Roberto, Doerner, Thomas, Fautrel, Bruno, Benedetti, Fabrizio, Pieper, Burkhard, Jang, Minjun
Publicado 2021